Genetic polymorphisms in the MDR1 gene can influence individual responses to drugs. These genetic variations can affect the expression and functionality of P-glycoprotein, leading to inter-individual differences in drug efficacy and toxicity. Identifying these polymorphisms is essential for personalized medicine approaches, where treatments are tailored based on a patient's genetic makeup.
